SION Sionna Therapeutics, Inc. Yalpi foyda bo'yicha marjinallik

Sionna Therapeutics, Inc. (SION) korporativ emblemasi va logotipi

Sionna Therapeutics Inc (SION) kistik fibroz terapiyasi bo'yicha o'zining noyob ilmiy poydevori va intellektual mulki tufayli yaratilgan yengib bo'lmas kirish to'siqlaridan foyda ko'rmoqda. Ushbu grafik yalpi foyda darajasi orqali ushbu barqarorlikni vizuallashtiradi, bunda ko'rsatkich 0.00 darajasiga yetdi. Biroq, muvaffaqiyat sinov natijalari va kapitalga bog'liq bo'lib, kichik molekulalar uchun II bosqich klinik sinovlarining yakunlanishi asosiy o'sish katalizatori bo'lib xizmat qiladi.

Yalpi foyda bo'yicha rentabellik: Sionna Therapeutics Inc (SION) 08.02.2025 - 20.11.2026 uchun

sionnatx.com (SION) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:SION, Sionna Therapeutics, Inc.
Sionna Therapeutics Inc yetakchi tovari

Xavfsizlik zaxirasi yuqori bo'lgan aktivlarni tanlash uchun, bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini tahlil qilish juda muhimdir, chunki bu resurslarni boshqarish samaradorligini baholash imkonini beradi. Ushbu ko'rsatkich Sionna Therapeutics Inc (SION) kompaniyasining monopolga qarshi kurashidagi R&D jarayonlarining operatsion rentabelligini o'lchaydi, GURU.Markets platformasidagi o'rtacha yalpi foyda marjasi esa kistik fibrozni davolash uchun dori vositalarini ishlab chiqishning haqiqiy xarajatlarini aks ettiradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|PRME - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Taysha TSHA|QURE: Yalpi marja|Yalpi foyda bo'yicha rentabellik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik